Phase IIb trial of Multimeric-001 vaccine (M-001) in patients with Influenza

Trial Profile

Phase IIb trial of Multimeric-001 vaccine (M-001) in patients with Influenza

Recruiting
Phase of Trial: Phase II

Latest Information Update: 10 Aug 2016

At a glance

  • Drugs Influenza virus vaccine (Primary)
  • Indications Influenza virus infections
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 10 Aug 2016 Status changed from planning to recruiting, as reported in a BiondVax Pharmaceuticals media release.
    • 27 Apr 2016 According to BiondVax media release, company expected to initiate this trial in 2016.
    • 19 Jun 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top